Literature DB >> 23752206

An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.

Joseph E Doherty1, Lauren E Woodard, Adham S Bear, Aaron E Foster, Matthew H Wilson.   

Abstract

Transposons permit permanent cellular genome engineering in vivo. However, transgene expression falls rapidly postdelivery due to a variety of mechanisms, including immune responses. We hypothesized that delaying initial transgene expression would improve long-term transgene expression by using an engineered piggyBac transposon system that can regulate expression. We found that a 2-part nonviral Tet-KRAB inducible expression system repressed expression of a luciferase reporter in vitro. However, we also observed nonspecific promoter-independent repression. Thus, to achieve temporary transgene repression after gene delivery in vivo, we utilized a nonintegrating version of the repressor plasmid while the gene of interest was delivered in an integrating piggyBac transposon vector. When we delivered the luciferase transposon and repressor to immunocompetent mice by hydrodynamic injection, initial luciferase expression was repressed by 2 orders of magnitude. When luciferase expression was followed long term in vivo, we found that expression was increased >200-fold compared to mice that received only the luciferase transposon and piggyBac transposase. We found that repression of early transgene expression could prevent the priming of luciferase-specific T cells in vivo. Therefore, transient transgene repression postgene delivery is an effective strategy for inhibiting the antitransgene immune response and improving long-term expression in vivo without using immunosuppression.

Entities:  

Keywords:  gene transfer; inducible expression; piggyBac

Mesh:

Substances:

Year:  2013        PMID: 23752206      PMCID: PMC3752539          DOI: 10.1096/fj.13-232090

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  53 in total

1.  Lentiviral-mediated RNAi in vivo silencing of Col6a1, a gene with complex tissue specific expression pattern.

Authors:  Kosjenka Frka; Nicola Facchinello; Claudia Del Vecchio; Andrea Carpi; Matteo Curtarello; Rina Venerando; Alessia Angelin; Cristina Parolin; Paolo Bernardi; Paolo Bonaldo; Dino Volpin; Paola Braghetta; Giorgio M Bressan
Journal:  J Biotechnol       Date:  2009-03-06       Impact factor: 3.307

2.  Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.

Authors:  A Khanna; A E Morelli; C Zhong; T Takayama; L Lu; A W Thomson
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

3.  Hyperactive piggyBac gene transfer in human cells and in vivo.

Authors:  Joseph E Doherty; Leslie E Huye; Kosuke Yusa; Liqin Zhou; Nancy L Craig; Matthew H Wilson
Journal:  Hum Gene Ther       Date:  2011-12-14       Impact factor: 5.695

4.  Intravitreal adenoviral gene transfer evokes an immune response in the retina that is directed against the heterologous lacZ transgene product but does not limit transgene expression.

Authors:  S Isenmann; S Engel; S Kügler; C Gravel; M Weller; M Bähr
Journal:  Brain Res       Date:  2001-02-23       Impact factor: 3.252

5.  Gene transfer into genomes of human cells by the sleeping beauty transposon system.

Authors:  Aron M Geurts; Ying Yang; Karl J Clark; Geyi Liu; Zongbin Cui; Adam J Dupuy; Jason B Bell; David A Largaespada; Perry B Hackett
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

6.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

Authors:  Steven E Raper; Narendra Chirmule; Frank S Lee; Nelson A Wivel; Adam Bagg; Guang-ping Gao; James M Wilson; Mark L Batshaw
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

7.  Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes.

Authors:  Yozo Nakazawa; Sunandan Saha; Daniel L Galvan; Leslie Huye; Lisa Rollins; Cliona M Rooney; Matthew H Wilson
Journal:  J Immunother       Date:  2013-01       Impact factor: 4.456

8.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.

Authors:  Lajos Mátés; Marinee K L Chuah; Eyayu Belay; Boris Jerchow; Namitha Manoj; Abel Acosta-Sanchez; Dawid P Grzela; Andrea Schmitt; Katja Becker; Janka Matrai; Ling Ma; Ermira Samara-Kuko; Conny Gysemans; Diana Pryputniewicz; Csaba Miskey; Bradley Fletcher; Thierry VandenDriessche; Zoltán Ivics; Zsuzsanna Izsvák
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

9.  Comparative analysis of the recently discovered hAT transposon TcBuster in human cells.

Authors:  Lauren E Woodard; Xianghong Li; Nirav Malani; Aparna Kaja; Robert H Hice; Peter W Atkinson; Frederic D Bushman; Nancy L Craig; Matthew H Wilson
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

Authors:  Amit C Nathwani; Edward G D Tuddenham; Savita Rangarajan; Cecilia Rosales; Jenny McIntosh; David C Linch; Pratima Chowdary; Anne Riddell; Arnulfo Jaquilmac Pie; Chris Harrington; James O'Beirne; Keith Smith; John Pasi; Bertil Glader; Pradip Rustagi; Catherine Y C Ng; Mark A Kay; Junfang Zhou; Yunyu Spence; Christopher L Morton; James Allay; John Coleman; Susan Sleep; John M Cunningham; Deokumar Srivastava; Etiena Basner-Tschakarjan; Federico Mingozzi; Katherine A High; John T Gray; Ulrike M Reiss; Arthur W Nienhuis; Andrew M Davidoff
Journal:  N Engl J Med       Date:  2011-12-10       Impact factor: 176.079

View more
  6 in total

1.  Genome Engineering Renal Epithelial Cells for Enhanced Volume Transport Function.

Authors:  Matthew H Wilson; Ruth Ann Veach; Wentian Luo; Richard C Welch; Shuvo Roy; William H Fissell
Journal:  Cell Mol Bioeng       Date:  2019-09-25       Impact factor: 2.321

2.  Temporal self-regulation of transposition through host-independent transposase rodlet formation.

Authors:  Lauren E Woodard; Laura M Downes; Yi-Chien Lee; Aparna Kaja; Eyuel S Terefe; Matthew H Wilson
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

3.  Kidney-specific transposon-mediated gene transfer in vivo.

Authors:  Lauren E Woodard; Jizhong Cheng; Richard C Welch; Felisha M Williams; Wentian Luo; Leslie S Gewin; Matthew H Wilson
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

4.  Functional analysis of the catalytic triad of the hAT-family transposase TcBuster.

Authors:  Lauren E Woodard; Felisha M Williams; Isria C Jarrett; Matthew H Wilson
Journal:  Plasmid       Date:  2021-01-18       Impact factor: 3.466

5.  Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy.

Authors:  Mario Di Matteo; Emira Samara-Kuko; Natalie J Ward; Simon N Waddington; Simon N Waddingon; John H McVey; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2014-07-18       Impact factor: 11.454

6.  Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo.

Authors:  Richard T O'Neil; Sunandan Saha; Ruth Ann Veach; Richard C Welch; Lauren E Woodard; Cliona M Rooney; Matthew H Wilson
Journal:  Nat Commun       Date:  2018-04-10       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.